How big is the Antibiotic Resistance Market?

The Antibiotic Resistance Market size is expected to reach USD 8.80 billion in 2024 and grow at a CAGR of 5.46% to reach USD 11.5 billion by 2029. Read More

What is the current Antibiotic Resistance Market size?

In 2024, the Antibiotic Resistance Market size is expected to reach USD 8.80 billion. Read More

Who are the key players in Antibiotic Resistance Market?

AbbVie, Merck & Co. Inc., Pfizer Inc, Novartis AG and Basilea Pharmaceutica Ltd. are the major companies operating in the Antibiotic Resistance Market. Read More

Which is the fastest growing region in Antibiotic Resistance Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Antibiotic Resistance Market?

In 2024, the North America accounts for the largest market share in Antibiotic Resistance Market. Read More

What years does this Antibiotic Resistance Market cover, and what was the market size in 2023?

In 2023, the Antibiotic Resistance Market size was estimated at USD 8.32 billion. The report covers the Antibiotic Resistance Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Antibiotic Resistance Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Antibiotic Resistance Market Share

Statistics for the 2023 & 2024 Antibiotic Resistance market share, created by Mordor Intelligence™ Industry Reports. Antibiotic Resistance share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Antibiotic Resistance Industry

The antibiotic resistance market is moderately consolidated. Increasing innovation and investment for various public and private organizations are expected to intensify market rivalry worldwide. The players collaborate with other players to develop and promote their products and thus gain recognition in the market. The major players in the market include AbbVie, collaborating Merck & Co. Inc., Pfizer Inc., Novartis AG, and Basilea Pharmaceutica Ltd.